Pulmonary Langerhans' cell histiocytosis (LCH): Epidemiology and clinical courses

Internal Medicine

Volumn 40, Issue 10, 2001, Pages 981-982

  Nagai, S ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Corticosteroid treatment; Eosinophilic granuloma of the lung; Interstitial lung disease; Primary pulmonary histiocytosis; Recurrent pneumothorax; Smokers

Indexed keywords

CLADRIBINE; CORTICOSTEROID;

AGE DISTRIBUTION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE COURSE; DRUG EFFECT; DRUG RESPONSE; EDITORIAL; EOSINOPHILIC GRANULOMA; FOLLOW UP; HEALTH SURVEY; HISTIOCYTOSIS X; HUMAN; INCIDENCE; INTERSTITIAL LUNG DISEASE; JAPAN; PREDICTION; PREVALENCE; PROGNOSIS; QUESTIONNAIRE; SEX RATIO; SMOKING;

EID: 0034753373     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.40.981     Document Type: Editorial

References (11)

1. Adult pulmonary Langerhans' cell histiocytosis
2. Pulmonary Langerhans' cell histiocytosis: Molecular analysis of clonality
3. Open lung biopsy for chronic diffuse infiltrative lung disease: Clinical, roentgenographic, and physiological correlations in 502 patients
4. Clinico-epidemiological features of pulmonary histiocytosis X
5. Pulmonary eosinophilic granuloma-Clinical analysis of 17 patients
6. Pulmonary Langerhans' cell granulomatosis. A clinicopathologic study of 48 cases
7. The pathology of smoking-related lung diseases
8. Pulmonary veno-occlusive disease in pulmonary Langerhans' cell granulomatosis
9. Severe pulmonary hypertension in histiocytosis X
10. Clinical and radiological feature lung function and therapeutic results in pulmonary histiocytosis X
11. Cladribine activity in adult Langerhans cell histioctosis